Terumo Blood and Cell Technologies Appoints Gene Stellon to Lead Innovation and Development
By: Colorado BioScience Association Date: 04/06/2022
Terumo Blood and Cell Technologies, a medical technology company, recently appointed Gene Stellon as Senior Vice President, Innovation and Development (I&D). He will serve on the Executive Management Committee.
Gene joins Terumo Blood and Cell Technologies from Medtronic, where he served as the Vice President, Research and Development (R&D) Surgical Energy & Safety and Gynecological Health (GYN) within Surgical Innovations. Throughout his career, he has held successive leadership roles in R&D, including at US Surgical as a manufacturing engineer supporting access and ligation devices along with surgical staplers. Gene served in the U.S. Air Force and the Connecticut, Air National Guard, retiring in 2015.
Terumo Blood and Cell Technologies specializes in products that collect and process blood and cells. Innovation and development are at the forefront of the company’s efforts. The company spends three times the industry average funding technology advances – making this I&D role critical. Such investment has been instrumental in funding new innovations including those for plasma collections and the cell and gene therapy industry.
Gene will lead the I&D department for Terumo Blood and Cell Technologies with focus on building a strong pipeline of future innovations. He will focus on effectively launching projects in development across our portfolio into emerging growth markets that will ultimately help us touch more patients’ lives.
Find out more in the press release.